(Q44086304)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Argiris Symeonidis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Peter Valent

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sabine Blum

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

18

U Platzbecker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

6

P Fenaux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

5

J Cermak

1 reference

21 January 2020

U Germing

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

B Hildebrandt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Kelaidi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Pfeilstöcker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

T Nösslinger

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Sekeres

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Maciejewski

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

D Haase

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Schanz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Seymour

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Kenealy

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Weide

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Lübbert

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

K Götze

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Stauder

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

K-A Kreuzer

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Schlenk

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A Ganser

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

W-K Hofmann

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Aul

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

O Krieger

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A Kündgen

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Haas

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Hasford

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A Giagounidis

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

13 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1286-1292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289990%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.391

21 January 2020

exact match

0 references

cites work

Distinct haematological disorder with deletion of long arm of no. 5 chromosome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

https://api.crossref.org/works/10.1038%2FLEU.2011.391

1 reference

7 January 2021

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Advances in the 5q- syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Cytogenetic characteristics and prognosis analysis in 231 myelodysplastic syndrome patients from a single institution

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.391

7 January 2021